일시 : 2018년 10월 25일 (목), 장소 : 서울아산병원 동관6층 대강당
08:00-08:50 Registration 사회 : 이성종 사무총장
08:55-09:00 Welcome remark 김용만 회장
KGOG Workshop & Symposium
09:00-10:00 Ovary-Fallopian Tube TSC Workshop 좌장 : 강석범 (국립암센터), 이정원 (성균관의대)
Active studies, Protocol under development

Active studies
- 전체 STUDY OVERVIEW : 김기동 (서울의대)
- KGOG 3030 POPOPO, Oncothermia & chemotherapy 김기동 (서울의대)
- KGOG 3038 MOCCA Recurrent clear cell ca - Durvalumab vs SoC chemo 김기동 (서울의대)
- KGOG 3037 NRG-GY005 Olaparib+cediranib vs olaparib vs cediranib vs SoC chemo in PR/RR ova ca TBD
- KGOG 3043 ACRIN EAE161 PERFUSION CT IN REC OV CA 정현훈 (서울의대) 
- KGOG 3045 AMBITION A pilot study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer 이정윤 (연세의대)
- KGOG 3046 FRONT-LINE A phase II study of Neoadjuvant chemotherapy plus Durvalumab and Tremelimumab in Advanced-stage ovarian cancer 이정윤 (연세의대)
Proposal of new concepts
- OV 1704 Effect of GNRHa on Chemotherapy- Induced Early Menopause in GY CANCER 최민철 (차의과학대학)
- OV 1808 난소암 환자의 정밀의료 구현을 위한 차세대 염기서열 분석 유전체 패널검사를 이용한 한국형 난소암 유전자 코호트 구축 연구 김지혜 (성균관의대)
New Proposal  
10:00-10:30 Coffee break
Special Lecture-I 좌장 : 김용만 회장 (울산의대)
10:30-10:35 공로패 증정 및 기념인사
10:35-11:00 기념강연
Clinical trials which have been performed by me as a doctor at my life
박상윤 (국립암센터)
Special Lecture-II 좌장 : 김병기 (성균관의대), 이철민 (인제의대)
11:00-11:40 PARP Inhibitors in Gynecologic Cancers Robert Mannel
(Chairman, NRG Oncology Group
Director, Stephenson Cancer Center, Univ. of Oklahoma, USA
Q&A
11:40-12:20 CENT-EAST-A New Trial Group in Central-Asia Murat Gultekin
(Hacettepe Univ. Faculty of Medicine,Turkey
Q&A
12:20-13:30 Lunch
Special Symposium 좌장 : 강순범 (건국의대), 김재원 (서울의대)
13:30-14:00 Estimands and Sensitivity Analysis (ICHE9,R1), and
Blockchain in Clinical Trials
남병호 (Herings)
14:00-14:20 Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer Focused on New Clinical Trial 김대연 (울산의대)
14:20-14:40 New KGOG committee 구성 및 소개
Rare tumor committee
정현훈 (서울의대)
14:40-15:00 Coffee break
15:00-16:00 Cervix-Vulva TSC Workshop 좌장 : 김대연 (울산의대), 장석준 (아주의대)
Active studies
- Ongoing protocol 진행상황: KGOG1027, KGOG1026, KGOG1008, KGOG1032, KGOG1023, KGOG1033, KGOG1036 김대연 (울산의대)
Protocol under development
- KGOG1039 Impact of Metformin on Survival Outcome in
Recurrent, Metastatic, and Persistent Cervical Cancer with
Paclitaxel, Cisplatin, and Bevacizumab: Open Label
Prospective Multicenter Randomized Control Trial
백민현 (한림의대)
- Current Clinical Trials of Immune Checkpoint Inhibitors in Cervical Cancers 김태훈 (서울의대)
New Proposal  
16:00-17:00 Uterine Corpus-GTN TSC Workshop 좌장 : 이종민 (경희의대), 박동춘 (가톨릭의대)
Active studies
- Ongoing protocol 진행상황: KGOG2009, KGOG2019, KGOG2020, KGOG2021 임소이 (가천의대)
Protocol under development
- Sandwich protocol in patients with stage III-IV
papillary serous, clear cell, and endometrioid
carcinoma of uterine corpus
이광범 (가천의대)
- Efficacy of adjuvant therapy in patients with low
or low-intermediate risk endometrial cancer
combined by positive peritoneal cytology:
a multicenter prospective single arm study
이방현 (한림의대)
Proposal of new concepts
- Rate of atypical hyperplasia or cancer in women
who underwent hysterectomy for non-atypical
endometrial hyperplasia
이나라, 김기동 (서울의대)
New Proposal  
17:00-17:20 정기총회
17:20- Closing remark 김용만 회장


일시 : 2018년 10월 25일 (목), 장소 : 서울아산병원 동관6층 소강당
08:00-08:40 Registration 사회 : 김종순 (KGOG)
08:45-08:50 Welcome remark 김용만 회장
연구간호사 교육 세션
  연구간호사 교육 세션 좌장 : 김재훈 (연세의대)
HeeSun Kim-Suh (Univ. of Oklahoma)
08:50-09:20 ICH E6 GCP(R2) 주요개정 내용과 고려사항 서경희 (Parexel) 
09:20-09:50 임상시험 기초통계 남병호 (Herings)
09:50-10:20 Function of the Protocol Support Committee.
Who are they and what roles do they play
HeeSun Kim-Suh
(Stephenson cancer center, Univ. of Oklahoma, USA)